A Study to Evaluate the Safety, Tolerability and Efficacy of RZ-001 in Combination With Valganciclovir (VGCV) and Atezolizumab/Bevacizumab in Subjects With Hepatocellular Carcinoma
A Study to Evaluate the Safety, Tolerability and Efficacy of RZ-001 in Combination With Valganciclovir (VGCV) and Atezolizumab/Bevacizumab in Subjects With Hepatocellular Carcinoma
Recruiting · NCT06695026 · Registry updated 2025-07-29Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Safety, Tolerability and Efficacy of RZ-001 in Combination With Valganciclovir (VGCV) and Atezolizumab/Bevacizumab in Subjects With Hepatocellular Carcinoma | Digestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, carcinoma, epithelial neoplasm, hepatocellular carcinoma, liver disorder, neoplasm | Recruiting | Phase 1 / Phase 2 | 2025-07-29 | NCT06695026 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Rznomics, Inc. | 3 |
9 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Catholic University of Korea, Seoul St. Mary's Hospital | Seoul | South Korea | 1 |
| Gangnam Severance Hospital | Seoul | South Korea | 30 |
| Kangbuk Samsung Medical Center | Seoul | South Korea | 4 |
| Korea University Guro Hospital | Seoul | South Korea | 57 |
| Kyungpook National University Hospital | Daegu | South Korea | 22 |
| Pusan National University Yangsan Hospital | Busan | South Korea | 6 |
| Samsung Medical Center | Seoul | South Korea | 170 |
| Seoul National University Hospital | Seoul | South Korea | 183 |
| Severance Hospital | Seoul | South Korea | 62 |